Witty Health Announces the Launch of CMS Reimbursable Physician Collaboration Suite and Initiates Clinical Development of Precision Therapeutic for Lung Cancer
Witty Health Announces the Launch of CMS Reimbursable Physician Collaboration Suite and Initiates Clinical Development of Precision Therapeutic for Lung Cancer
HOUSTON, Jan. 16, 2019 /PRNewswire-PRWeb/ -- Witty Health Inc., an oncology-focused digital health and a blockchain company has announced the launch of Physician-2-Physician collaboration platform for the global oncology community on OncoPower, an oncologist-designed platform that utilizes digital health and professional networking to improve cancer care and precision medicine. The company has also initiated the clinical development of Precision Therapeutic, which is an unique personalized digital therapeutic, for Lung Cancer
The OncoPower's Physician-2-Physician collaboration suite released today enables Oncologist-2-Oncologist, Oncologist-2- Virtual Tumor Board, Oncologist-2-Consensus Panel and Oncologist-2- Specialist consultations. The Center for Medicare and Medicaid Services (CMS) have regulations in place to reimburse these payments for the treating oncologists and consulting physicians. OncoPower Physician-2-Physician consult suite facilitates these consultations efficiently and help generate documentation that complies with these rules. Using OncoPower's physician collaboration suite, the treating and consulting physicians can generate documentation for each patient with specific CPT codes. The suite provides an easy to use option for Primary Care Physicians to consult oncologists while attending to cancer survivors. Please see FAQs: http://oncopower.org/oncFAQ/smartonc.html. Oncology providers, specialists and primary care physicians can join OncoPower at https://oncopower.org/OncCase.
The Company has also initiated clinical development of Precision Therapeutic, a first in its class personalized digital therapeutic for Lung Cancer. Lung cancer is the leading cause of cancer-related death in the world. With over 230,000 new lung cancer cases and 140,000 deaths in the US, there is a strong unmet need to improve outcomes with innovative precision medicine methods. Worldwide, an estimated 2.09 million new cases of lung cancer and 1.76 million deaths in 2018 as per WHO. OncoPower's Oncologist-2-Consensus Panel tool is a unique digital health tool for generating consensus precision care by a panel of multiple oncologists or a virtual tumor board. Witty Health intends to use the development of its Precision Therapeutic to objectively evaluate the impact that digital consensus care plans are having on treatment outcomes.
"We are happy to achieve this milestone and compliance which ensures that Oncologists, specialists and primary care physicians using our Physician-2-Physician collaboration suite are paid for their time and efforts" said Witty Health Co-Founder and Chief Oncologist, Karthik Koduru, MD. "The current one-size-fits-all approach to treating lung cancer patients is not improving outcomes as expected. We are certainly in need of exploring new technologies like artificial intelligence, digital health, and blockchain to improve outcomes and Quality of Life (QoL) particularly for lung cancer patients. The OncoPower Consensus building tool is a very innovative method to optimize personalized treatment plans and use the treating community to utilize best practices in real time."
The current digital health tools are being offered using traditional technologies. Witty Health is carefully researching and slowly implementing blockchain capabilities into the platform. Once fully built, OncoPower will be powered by a blockchain-integrated, digitally generated security called Onco, a class B non-voting security that will power the platform actions and serve as the fuel of the incentivized oncology market. With OncoPower, participants are both shareholders and users. They retain both the clinical and social benefits, as well as most of the financial benefits, via Onco distributed using transparent consensus algorithms.
"With an estimated 1.7 million new cancer cases expected this year alone, Oncologists need to begin to lean more heavily on peers, digital health, and patient engagement tools to improve access to evidence-based cancer care. While I am utterly impressed with the platform tools themselves, the best part of the OncoPower platform is that it is led by a team of Oncologists who know what is best for the cancer patients," stated Dr. Amitkumar Mehta, a Medical Oncologist and Hematologist at the University of Alabama School of Medicine, Birmingham, AL.
About OncoPower
OncoPower (https://oncopower.org/) is an oncologist-designed platform developed to create value for the global cancer community. It is HIPAA-compliant and uses integrated clinical care and social determinants of health (SDoH) approach. It is developed by Witty Health Inc, a Houston, TX based digital therapeutic company that approaches complex problems with smart and inventive solutions.
Media Contact:
Whitney Ahneman
Phone: (713) 470-2580
SOURCE Witty Health
Share this article